Error
xxx
Welcome to the European Forum for Good Clinical Practice
Activities  >  Events and Activities  >  EFGCP Webinar - Paediatric Clinical Trial Preparedness
Webinar
EFGCP Webinar - Paediatric Clinical Trial Preparedness
Delays in conducting and completing paediatric clinical trials are one of the major challenges researchers are facing when developing new medicines for children.
11 February 2021 - 17:00-18:30 CETAdd to calendar
Description
Description

Delays in conducting and completing paediatric clinical trials are one of the major challenges researchers are facing when developing new medicines for children.

The EMA Paediatric Action Plan has addressed this issue by commissioning a new guidance document to the European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA) that sets out recommendations for clinical trial preparedness focusing on factors which facilitate or hamper the conduct of trials in children.

"Trial preparedness" is defined as a structured assessment of the key factors that could increase the likelihood of a smooth and timely course of a paediatric clinical trial, integrating information from multiple stakeholders on what is possible within individual studies and therefore also for the overall drug development plan within which a trial is embedded. These recommendations are moving beyond the definition of clinical trial "feasibility" to present a global determination of all aspects of a trial that need to be prepared with the active involvement and collaboration of all stakeholders. Active discussion of these aspects within all regulatory applications will also help resolving some of the hurdles faced during such interactions.

In this webinar, members of the Enpr-EMA working group for this guidance will discuss these recommendations and provide some practical insights from for Industry, Research Networks and Patients, how to operationalize these ideas in practice.

Link to the new guidance: Click Here

Agenda:
  • Martine Dehlinger-Kremer - PRA Health Sciences & EUCROF: Introduction
  • Angeliki Siapkara - MHRA: Guidance Presentation
  • Claudio Fracasso - Pfizer: Industry Point of View
  • Donato Bonifazi - Teddy Network: Research Network Point of View
  • Dimitrios Athanasiou - PDCO: Patient Point of View
  • Angelika Joss - MSD: Panel Discussion and Q&A Moderation


Webinar Fee:
  • EFGCP Members: 29€
  • Non EFGCP Members: 49€
  • EFGCP offers free seats to patients (within the limit of available seats), please contact Ingrid Heyne at ingrid.heyne@efgcp.eu if you are interested.

Ask us
If you have any question, send us an email to info@efgcp.eu
Follow us
Linkedin
Twitter
EFGCP
European Forum for Good Clinical Practice
Rue de Washington 40
B-1050 Brussels - Belgium
Tel : +32 2 732 87 83
TVA : BE 0457 666 685